A health impact assessment of increased aspirin use in Wales.
W R
WR
Williams
D001241:Aspirin / Q000009:adverse effects* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000517:prevention & control; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D014852:Wales
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin